Company intelligence / Profile preview

Thessalus Capital

New York, New York, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Thessalus Capital is a healthcare-focused investment firm that specializes in the life sciences, biotechnology, and medical technology sectors. The firm utilizes a rigorous, science-driven approach to identify and invest in companies developing transformative medical treatments and technologies. Their portfolio includes a mix of public and private companies across various stages of development, from early-stage venture to established commercial entities. By combining medical expertise with financial analysis, Thessalus Capital aims to generate superior returns while advancing global health outcomes.

Industry: Investors

Beyond the preview

Go deeper on Thessalus Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thessalus Capital.

Explore the full profile